Mild Cognitive Impairment Subtypes Are Associated With Peculiar Gait Patterns in Parkinson's Disease

Marianna Amboni1,2, Carlo Ricciardi3,4, Sofia Cuoco1

  • 1Department of Medicine, Surgery and Dentistry, Center for Neurodegenerative Diseases (CEMAND), University of Salerno, Fisciano, Italy.

Abstract

Insights

Parkinson's disease patients with mild cognitive impairment (PD-MCI) show poorer gait compared to those without cognitive decline. Specific PD-MCI subtypes, particularly those involving memory, exhibit worse gait, especially during dual-task activities.

Area of Science:

  • Neurology
  • Movement Disorders
  • Cognitive Neuroscience

Background:

  • Mild cognitive impairment (MCI) is common in Parkinson's disease (PD), increasing the risk for dementia (PDD).
  • Early detection of PD-MCI and its biomarkers is crucial due to PDD's association with disability and increased healthcare costs.

Purpose of the Study:

  • To compare gait patterns across different subtypes of PD-MCI.
  • To investigate the association between specific gait features and particular MCI subtypes in PD patients.

Main Methods:

  • 67 PD patients underwent clinical and cognitive assessments to diagnose PD-MCI and its subtypes.
  • Gait analysis was performed using a motion capture system in ON-state, under single and dual-task conditions.
  • Statistical analysis included t-tests, Kruskal-Wallis tests with post hoc analysis, and correlation analysis.

Main Results:

  • PD-MCI patients exhibited poorer gait patterns than no-PD-MCI patients across all tested tasks.
  • Multiple-domain PD-MCI and amnestic PD-MCI subtypes were associated with significantly worse gait, particularly during dual-task performance.

Conclusions:

  • Cognitive impairment magnitude and memory dysfunction in PD-MCI correlate with increased dynamic unbalance, especially during dual tasks.
  • These findings suggest progressive involvement of posterior cortical networks in PD-MCI, impacting gait and balance.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
778
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
415
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
200
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
709
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
234